LAM cells are caused by mutations in the tuberous sclerosis complex genes (TSC1/TSC2) that result in activation of the mammalian target of rapamycin (mTOR), which regulates cellular growth and proliferation [2]. This evidence concerns the gene TSC2 and lymphangioleiomyomatosis.